Table 3.

Pooled HRs and 95%CIs from the meta-analysis of RFS.

Non-coding RNA	Model	No. of studies	No. of patients	HR (95%CI)	P-value	Heterogeneity (%)	(I2, P-value)
miR-27a(rs895819)	CT vs. TT	3	1,388	1.00 (0.83, 1.22)	0.963	23.7	0.270
	CC vs. TT	3	1,388	0.92 (0.72, 1.17)	0.483	0.0	0.827
	CT+CC vs.TT	4	1,400	0.99 (0.84, 1.18)	0.921	0.0	0.413
	CC vs. CT+TT	2	950	0.90 (0.71, 1.14)	0.373	0.0	0.933
miR-423(rs6505162)	AC vs. CC	3	925	1.34 (1.03, 1.73)	0.026	24.1	0.268
	AA vs. CC	3	925	0.89 (0.47, 1.70)	0.730	0.0	0.870
	AC+AA vs. CC	2	796	1.37 (1.01, 1.86)	0.042	29.0	0.235
miR-492(rs2289030)	GG vs. CC	2	796	1.10 (0.56, 2.15)	0.785	0.0	0.438
	GG vs. GC+CC	2	796	0.98 (0.65, 1.46)	0.910	0.0	0.894
miR-608(rs4919510)	CG vs. GG	2	912	0.73 (0.60, 0.88)	0.001	0.0	0.401
	CC vs. GG	2	912	0.82 (0.49, 1.35)	0.429	0.0	0.128
miR-146(rs2910164)	GC vs. CC	2	795	0.84 (0.57, 1.26)	0.400	60.4	0.080
	GG vs. CC	3	1,203	0.89 (0.66, 1.21)	0.462	37.1	0.189
	GG vs. GC+CC	3	889	0.89 (0.56, 1.40)	0.608	60.8	0.078
	GC+GG vs. CC	2	795	0.79 (0.35, 1.78)	0.570	83.0	0.015
	CC vs. GC+GG	2	751	1.37 (0.59, 3.20)	0.470	82.1	0.018
miR-196a2(rs11614913)	CT vs. TT	2	795	0.71 (0.49, 1.03)	0.074	0.0	0.715
	CC vs. TT	2	795	0.84 (0.54, 1.29)	0.423	0.0	0.369
	CT+CC vs. TT	2	795	0.76 (0.53, 1.08)	0.123	0.0	0.513

RFS, relapse-free survival; HR, hazard ratio; CI, confidence interval. Bolded values are expressed as values of statistical significance.